The combination of MGTA-145 and plerixafor demonstrated effective hematopoietic stem cell (HSC) mobilization in patients with multiple myeloma ... stimulating factor (G-CSF) or G-CSF with or ...

The basis of peptide vaccination is the observation that leukemia cells can act as antigen-presenting cells (APCs) that cleave endogenous leukemia antigens in their proteasome and present them on ...

Multiple Myeloma (MM) is an incurable blood cancer, leading to weakened immunity, bone damage, and other serious health ...

GSK is carving out a niche for Blenrep in the second-line multiple myeloma setting, for which it projects multi-blockbuster ...

Multiple myeloma is the second most common hematologic malignancy, but there is a treatment gap for patients with disease ...

Our additional preliminary studies demonstrate that dual targeting of multiple myeloma cells and BM-CAFs by CAR-T cells is ...

The department used its new system for determining whether a condition is service-connected to give affected veterans access ...

Don M. Benson, MD, PhD, has cared for patients at James Cancer Hospital in Ohio for 22 years, where he and his team see approximately 10,000 patient visits each year.

Revlimid (lenalidomide) is a brand-name oral capsule prescribed to treat multiple myeloma and certain other blood cell cancers in adults. This article covers topics such as side effects ...

Doctors do not usually recommend surgery for multiple myeloma. However, it may be necessary to repair damaged bones, replace bone marrow, or treat spinal cord compression. Surgery to treat ...